Quantbot Technologies LP Tcr2 Therapeutics Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.11 - $2.94 $1,688 - $2,352	-800 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.4 - $4.71 $19,200 - $37,680	-8,000 Reduced 90.91%	800 $2,000
Q4 2021 Feb 11, 2022	BUY	$4.58 - $8.34 $25,190 - $45,870	5,500 Added 166.67%	8,800 $41,000
Q3 2021 Nov 09, 2021	BUY	$8.44 - $18.35 $27,852 - $60,555	3,300 New	3,300 $28,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.